SCHEMBL5165908

SCHEMBL5165908

CCCCCCC(O)CCC(O)CCCCCCCC(=O)O

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 3/20 0.96
▸ FFAR1 O14842 3/20 0.96
▸ GPR84 Q9NQS5 9/20 0.68
▸ PPARG P37231 7/20 0.68
▸ PPARD Q03181 7/20 0.68
▸ PPARA Q07869 7/20 0.68
▸ HDAC11 Q96DB2 5/20 0.68
▸ TSHR P16473 4/20 0.68
▸ PTPN1 P18031 3/20 0.68
▸ ALDH1A1 P00352 2/20 0.68
▸ TLR2 O60603 2/20 0.68
▸ TDP1 Q9NUW8 2/20 0.68
▸ FABP4 P15090 2/20 0.68
▸ SLC22A6 Q4U2R8 1/20 0.68
▸ SLC22A8 Q8TCC7 1/20 0.68
▸ MEN1 O00255 1/20 0.68
▸ ESR1 P03372 1/20 0.68
▸ ALOX15 P16050 1/20 0.68
▸ PDE4A P27815 1/20 0.68
▸ KMT2A Q03164 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31524395 1.00 FFAR4 (0.96) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL17133174 1.00 FFAR4 (0.96) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL31524404 1.00 FFAR4 (0.96) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL22400854 1.00 FFAR4 (0.96) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL22400866 1.00 FFAR4 (0.96) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL22400909 1.00 FFAR4 (0.96) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL22400855 1.00 FFAR4 (0.96) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL22400849 1.00 FFAR4 (0.96) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL22400946 1.00 FFAR4 (0.96) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL31524392 1.00 FFAR4 (0.96) FFAR4FFAR1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026406-A1 THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM DUST ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2023-01-26 — — US claimed
CN-115532070-A Reverse osmosis membrane scale inhibitor for sewage treatment and application thereof 山东华特水处理科技有限公司 2022-12-30 — — CN claimed
WO-2021158990-A1 THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM DUST ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-08-12 — — WO claimed
EP-1457201-B1 Cosmetic composition containing a polyester of a hydrocarboxylated carboxylic acid triglyceride and an oil with a molar mass from 650 to 1000 g/ml OREAL (FR) 2007-04-11 — — EP claimed
US-6869597-B2 Cosmetic care or makeup composition for a keratin material comprising at least one photoprotective agent and at least one ester comprising an aromatic group L'OREAL S.A. (FR) 2005-03-22 — — US claimed
US-20040241121-A1 Cosmetic composition comprising at least one polyester resulting from esterification of at least one triglyceride of hydroxylated carboxylic acid(s) and also comprising at least one pasty compound L'OREAL S.A. (FR) 2004-12-02 — — US claimed
US-20040241198-A1 Cosmetic composition comprising at least one polyester resulting from esterification of at least one triglyceride of hydroxylated carboxylic acid(s) and at least one oil with a molar mass of 650 to 10 000 g/mol L'OREAL S.A. (FR) 2004-12-02 — — US claimed
US-20040166130-A1 Lanolin-free cosmetic composition comprising a hydroxylated fatty acid aromatic ester L'OREAL (FR) 2004-08-26 — — US claimed
US-20030077234-A1 Cosmetic care or makeup composition for a keratin material comprising at least one photoprotective agent and at least one ester comprising an aromatic group L'OREAL. 2003-04-24 — — US claimed
US-12195645-B2 Hot-melt adhesive for manufacturing disposable hygiene products BOSTIK SA (FR) 2025-01-14 — — US disclosed
EP-3880765-B1 IMPROVED HOT-MELT ADHESIVE FOR MANUFACTURING DISPOSABLE HYGIENE PRODUCTS BOSTIK SA (FR) 2024-04-10 — — EP disclosed
US-20230026406-A1 THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM DUST ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2023-01-26 — — US disclosed
CN-115532070-A Reverse osmosis membrane scale inhibitor for sewage treatment and application thereof 山东华特水处理科技有限公司 2022-12-30 — — CN disclosed
US-20220017796-A1 IMPROVED HOT-MELT ADHESIVE FOR MANUFACTURING DISPOSABLE HYGIENE PRODUCTS BOSTIK SA (FR) 2022-01-20 — — US disclosed
US-7250159-B1 Compositions comprising at least one ester of at least one hydroxylated aliphatic compound L'ORéAL S.A. (FR) 2007-07-31 — — US disclosed
US-6869597-B2 Cosmetic care or makeup composition for a keratin material comprising at least one photoprotective agent and at least one ester comprising an aromatic group L'OREAL S.A. (FR) 2005-03-22 — — US disclosed
US-20040241121-A1 Cosmetic composition comprising at least one polyester resulting from esterification of at least one triglyceride of hydroxylated carboxylic acid(s) and also comprising at least one pasty compound L'OREAL S.A. (FR) 2004-12-02 — — US disclosed
US-20040241198-A1 Cosmetic composition comprising at least one polyester resulting from esterification of at least one triglyceride of hydroxylated carboxylic acid(s) and at least one oil with a molar mass of 650 to 10 000 g/mol L'OREAL S.A. (FR) 2004-12-02 — — US disclosed
US-20040166130-A1 Lanolin-free cosmetic composition comprising a hydroxylated fatty acid aromatic ester L'OREAL (FR) 2004-08-26 — — US disclosed
US-20030077234-A1 Cosmetic care or makeup composition for a keratin material comprising at least one photoprotective agent and at least one ester comprising an aromatic group L'OREAL. 2003-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040241198-A1 Cosmetic composition comprising at least one polyester resulting from esterification of at least one triglyceride of hydroxylated carboxylic acid(s) and at least one oil with a molar mass of 650 to 10 000 g/mol FABP4, KRT18, PPARG FFAR4 70/4885FFAR1 62/4885GPR84 90/4885
US-20040166130-A1 Lanolin-free cosmetic composition comprising a hydroxylated fatty acid aromatic ester CYP51A1, ELOVL3, ELOVL5 FFAR4 29/4885FFAR1 38/4885GPR84 2334/4885
US-20040241121-A1 Cosmetic composition comprising at least one polyester resulting from esterification of at least one triglyceride of hydroxylated carboxylic acid(s) and also comprising at least one pasty compound KRT18, CUTA, CETP FFAR4 401/4885FFAR1 412/4885GPR84 1055/4885
US-20030077234-A1 Cosmetic care or makeup composition for a keratin material comprising at least one photoprotective agent and at least one ester comprising an aromatic group KRT18, CUTA, TYR FFAR4 3075/4885FFAR1 3456/4885GPR84 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback